Effects of two combined oral contraceptives containing ethinyl estradiol 30 μg combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles …
R Yildizhan, B Yildizhan, E Adali, P Yoruk… - Archives of gynecology …, 2009 - Springer
Objective The aim of this study is to compare the effect of ethinyl estradiol 0.03
mg/gestodene 0.075 mg (EE/GSD) with ethinylestradiol 0.03 mg/drospirenone 3 mg …
mg/gestodene 0.075 mg (EE/GSD) with ethinylestradiol 0.03 mg/drospirenone 3 mg …
The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)
WH Schneider, R Schmid, J Spona - Wiener Klinische …, 1981 - europepmc.org
Two single-phase combined low-dosage oral contraceptive preparations were tested with
respect to their effects on functional parameters of the menstrual cycle. Twenty young …
respect to their effects on functional parameters of the menstrual cycle. Twenty young …
Pharmacokinetics of gestodene and ethinyl estradiol after oral administration of a monophasic contraceptive
U Täuber, W Kuhnz, M Hümpel - American journal of obstetrics and …, 1990 - Elsevier
The pharmacokinetic and protein-binding properties of gestodene and ethinyl estradiol have
been investigated after single and multiple dosing in several studies in 83 healthy, young …
been investigated after single and multiple dosing in several studies in 83 healthy, young …
Clinical experience with a triphasic oral contraceptive
M Ulstein, E Svendsen, A Steier, H Bratt… - Acta obstetricia et …, 1984 - Taylor & Francis
A triphasic combined oral contraceptive containing fluctuating amounts of ethinylestradiol
and levonorge-strel was tested clinically in a multicenter trial at six hospitals in Norway. 367 …
and levonorge-strel was tested clinically in a multicenter trial at six hospitals in Norway. 367 …
Pharmacokinetics of gestodene in 12 women who received a single oral dose of 0.075 mg gestodene and, after a wash-out phase, the same dose during one …
W Kuhnz, C Gansau, A Fuhrmeister - Contraception, 1992 - Elsevier
The pharmacokinetics of gestodene (GEST) was determined in 12 healthy women (age 22
to 34 years), following single dose administration of 0.075 mg GEST. The same preparation …
to 34 years), following single dose administration of 0.075 mg GEST. The same preparation …
Clinical trial of a low dose combined oral contraceptive ('Ovranette')
GL Foss, KL Fotherby - Current Medical Research and Opinion, 1975 - Taylor & Francis
A combination of 150 µg. d-norgestrel with 30 µg. ethinyl oestradiol was administered to 120
women for a total of'767 cycles. No pregnancies occurred and cycle control was good, 99 …
women for a total of'767 cycles. No pregnancies occurred and cycle control was good, 99 …
A comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulation
C Fitzgerald, W Feichtinger, J Spona, M Elstein… - Advances in …, 1994 - Springer
Fifty-three women were randomly allocated to one of two combined low-dose monophasic
oral contraceptives (20 μg ethinyl estradiol with 75 μg gestodene or 20 μg ethinyl estradiol …
oral contraceptives (20 μg ethinyl estradiol with 75 μg gestodene or 20 μg ethinyl estradiol …
Efficacy and safety of a low-dose 21-day combined oral contraceptive containing ethinylestradiol 20μg and drospirenone 3mg
D Cibula, U Karck, HG Weidenhammer, J Kunz… - Clinical drug …, 2006 - Springer
Objective: The purpose of this study was to assess the efficacy and safety of a new low-dose
oral contraceptive containing ethinylestradiol 20μg and drospirenone 3mg (EE 20μg/drsp …
oral contraceptive containing ethinylestradiol 20μg and drospirenone 3mg (EE 20μg/drsp …
New progestins—clinical experiences: gestodene
D Shoupe - American journal of obstetrics and gynecology, 1994 - Elsevier
Gestodene, one of three new gonane progestins, is the most potent on a per weight basis in
regard to progestational effects and has little or no estrogenic effect. In in vivo animal …
regard to progestational effects and has little or no estrogenic effect. In in vivo animal …